Skip to main content
SpringerLink
Log in

Biological Therapy of Refractory Ulcerative Oral Lichen Planus with Plasma Rich in Growth Factors

  • Research letter
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Al-Hashimi I, Schifter M, Lockhart P, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(103 Suppl.):S25.e1–12.

    Google Scholar 

  2. Scully C, El-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985;14:431–58.

    Article  CAS  PubMed  Google Scholar 

  3. Yang H, Wu Y, Ma H, et al. Possible alternative therapies for oral lichen planus cases refractory to steroid therapies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:496–509.

    Article  PubMed  Google Scholar 

  4. Suresh SS, Chokshi K, Desai S, et al. Medical management of oral lichen planus: a systematic review. J Clin Diagn Res. 2016;10:ZE10–5.

    PubMed  Google Scholar 

  5. Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011;7:CD001168

  6. Eisen D, Ellis CN, Duell EA, et al. Effect of topical cyclosporine rinse on oral lichen planus: a double-blind analysis. N Engl J Med. 1990;23:290–4.

    Article  Google Scholar 

  7. Passeron T, Lacour JP, Fontas E, Ortonne JP. Treatment of oral erosive lichen planus with 1% pimecrolimus cream a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol. 2007;143:472–6.

    CAS  PubMed  Google Scholar 

  8. Becker JC, Houben R, Vetter CS, Bröker E. The carcinogenic potential of tacrolimus oinment beyond immune suppression: a hypothesis creating case report. BMC Cancer. 2006;6:7–13.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sloberg K, Hersie K, Mobacken H, Thilander H. Severe oral lichen planus remissions and maintenance with vitamin A analogues. J Oral Pathol. 1983;12:473–7.

    Article  CAS  PubMed  Google Scholar 

  10. Camisa C, Popovsky JL. Effective treatment of oral erosive lichen planus with thalidomide. Arch Dermatol. 2000;136:1442–3.

    Article  CAS  PubMed  Google Scholar 

  11. Kollner K, Wimmershoff H, Landthaler M, Hohenleutner U. Treatment of oral lichen planus with the 308-nm UVB excimer laser: early preliminary results in eight patients. Lasers Surg Med. 2003;33:158–60.

    Article  PubMed  Google Scholar 

  12. Cheng A, Nabb C. Oral erosive lichen planus treated with efalizumab. Arch Dermatol. 2006;142:680–2.

    Article  PubMed  Google Scholar 

  13. Lear JT, English JS. Erosive and generalizad lichen planus responsive to azathioprine. Clin Exp Dermatol. 1996;21:56–7.

    Article  CAS  PubMed  Google Scholar 

  14. Guyot AD, Farhi D, Ingeen-Huesz-Oro S, Bussel A, et al. Treatment of refractory erosive lichen planus with extracorporeal chemotherapy: 12 cases. Br J Dermatol. 2007;156:553–6.

    Article  CAS  PubMed  Google Scholar 

  15. Nousari HC, Goyal S, Anhalt GJ. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol. 1999;135:1420–1.

    Article  CAS  PubMed  Google Scholar 

  16. Ferguson MM, Simpson NB, Hammersley N. The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1984;58:283–7.

    Article  CAS  Google Scholar 

  17. EL-Komy MH, Hassan AS, Abdel Raheem HM, et al. Platelet-rich plasma for resistant oral erosions of pemphigus vulgaris: a pilot study. Wound Repair Regen. 2015;23:953–5.

    Article  PubMed  Google Scholar 

  18. Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release. 2012;157:29–38.

    Article  CAS  PubMed  Google Scholar 

  19. Anitua E, Murias-Freijo A, Alkhraisat MH, Orive G. Clinical, radiographical, and histological outcomes of plasma rich in growth factors in extraction socket: a randomized controlled clinical trial. Clin Oral Investig. 2015;19:589–600.

    Article  PubMed  Google Scholar 

  20. Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. J Periodontol. 2012;83:1028–37.

    Article  CAS  PubMed  Google Scholar 

  21. Zhou L, Cao T, Wang Y, et al. Frequently increased but functionally impaired CD4+CD25+ regulatory T cells in patients with oral lichen planus. Inflammation. 2016;39:1205–15.

    CAS  PubMed  Google Scholar 

  22. Tao XA, Xia J, Chen XB, et al. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis. 2010;16:76–82.

    Article  PubMed  Google Scholar 

  23. Wan YY, Flavell RA. ‘Yin-Yang’ functions of transforming growth factor beta and T regulatory cells in immune regulation. Immunol Rev. 2007;220:199–213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Cao T, Zhang H, Zhou L, et al. In vitro cell culture system optimization of keratinocytes from oral lichen planus (OLP) patients. Oral Dis. 2017;23:225–32.

    Article  CAS  PubMed  Google Scholar 

  25. Danielsson K, Ebrahimi M, Nylander E, et al. Alterations in factors involved in differentiation and barrier function in the epithelium in oral and genital lichen planus. Acta Derm Venereol. 2017;97:214–8.

    Article  PubMed  Google Scholar 

  26. Anitua E, Zalduendo MM, Prado R, et al. Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. J Biomed Mater Res A. 2015;103:1011–20.

    Article  CAS  PubMed  Google Scholar 

  27. Anitua E, Zalduendo M, Troya M, Orive G. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Clin Oral Investig. 2016;20:513–21.

    Article  PubMed  Google Scholar 

  28. Anitua E, Zalduendo M, Troya M, et al. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015;10:e0121713.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gunduz K, Demireli P, Inanir I, Nese N. Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in lichen planus. J Cutan Pathol. 2006;33:545–50.

    Article  PubMed  Google Scholar 

  30. Anitua E, Muruzabal F, Pino A, et al. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea. 2013;32:1380–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Laura Piñas and Mohammad Hamdan Alkhraisat contributed equally to the manuscript.

Authors and Affiliations

  1. Universidad Europea de Madrid, Madrid, Spain

    Laura Piñas

  2. Eduardo Anitua Foundation, c/o Jose Maria Cagigal 19, 01007, Vitoria, Spain

    Mohammad Hamdan Alkhraisat & Eduardo Anitua

  3. University General Hospital Gregorio Marañón, Madrid, Spain

    Ricardo Suarez Fernández

  4. Clínica Eduardo Anitua, Vitoria, Spain

    Eduardo Anitua

Authors
  1. Laura Piñas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Hamdan Alkhraisat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ricardo Suarez Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eduardo Anitua
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Anitua.

Ethics declarations

Funding

No funding was received for the conduct of this study.

Conflict of interest

Eduardo Anitua is the Scientific Director of BTI Biotechnology Institute (Vitoria, Spain) and the head of the Foundation Eduardo Anitua, Vitoria, Spain. Laura Piñas and Ricardo Suarez Fernández have no conflicts of interest directly relevant to the content of this article. Mohammad Hamdan Alkhraisat is a scientist at BTI Biotechnology Institute (Vitoria, Spain).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piñas, L., Alkhraisat, M.H., Fernández, R.S. et al. Biological Therapy of Refractory Ulcerative Oral Lichen Planus with Plasma Rich in Growth Factors. Am J Clin Dermatol 18, 429–433 (2017). https://doi.org/10.1007/s40257-017-0277-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-017-0277-x

Keywords

Search

Navigation